Journal of Toxicology Canada,” Atmospheric Environment, vol. 33, no. 16, pp. 2515– 2526, 1999. [16] K. S. Crump, “Manganese exposures in Toronto during use of the gasoline additive, methylcyclopentadienyl manganese tricarbonyl,” Journal of Exposure Analysis and Environmental Epidemiology, vol. 10, no. 3, pp. 227–239, 2000. [17] A. K. Bhuie and D. N. Roy, “Deposition of Mn from auto- motive combustion of methylcyclopentadienyl manganese tricarbonyl beside the major highways in the greater Toronto area, Canada,” Journal of the Air and Waste Management Association, vol. 51, no. 9, pp. 1288–1301, 2001. [18] B. Gulson, K. Mizon, A. Taylor et al., “Changes in manganese and lead in the environment and young children associated with the introduction of methylcyclopentadienyl manganese tricarbonyl in gasoline—Preliminary results,” Environmental Research, vol. 100, no. 1, pp. 100–114, 2006. [19] B. Gulson, K. Mizon, A. Taylor et al., “Longitudinal monitor- ing of selected elements in blood of healthy young children,” Journal of Trace Elements in Medicine and Biology, vol. 22, no. 3, pp. 206–214, 2008. [20] K. Bridbord and D. Hanson, “A personal perspective on the initial federal health-based regulation to remove lead from gasoline,” Environmental Health Perspectives, vol. 117, no. 8, pp. 1195–1201, 2009. [21] J. M. Davis, “Methylcyclopentadienyl manganese tricarbonyl: health risk uncertainties and research directions,” Environ- mental Health Perspectives, vol. 106, supplement 1, pp. 191– 201, 1998. [22] W. K. Boyes, “Essentiality, toxicity, and uncertainty in the risk assessment of manganese,” Journal of Toxicology and Environmental Health A, vol. 73, no. 2-3, pp. 159–165, 2010. [23] J. M. Davis, “Inhalation health risks of manganese: an EPA perspective,” NeuroToxicology, vol. 20, no. 2-3, pp. 511–518, 1999. [24] U.S. Environmental Protection Agency (USEPA), Fuels and fuel additives; waiver decision/circuit court remand. Fed Reg 59:42227-42247, 1994. [25] U.S. Environmental Protection Agency (USEPA) (2011), Comments on the Gasoline Additive MMT (methylcyclo- pentadienyl manganese tricarbonyl), 2011, http://www .epa.gov/otaq/regs/fuels/additive/mmt cmts.htm. [26] A. W. Garrison, M. G. Cipollone, N. L. Wolfe, and R. R. Swank, “Environmental fate of methylcyclopentadienyl manganese tricarbonyl,” Environmental Toxicology and Chemistry, vol. 14, no. 11, pp. 1859–1864, 1995. [27] G. L. Ter Haar, M. E. Griﬃng, and M. Brandt, “Methyl- cyclopentadienyl manganese tricarbonyl as an antiknock: composition and fate of manganese exhaust products,” Journal of the Air Pollution Control Association, vol. 25, no. 8, pp. 858– 860, 1975. [28] J. Zayed, B. Hong, and G. L’Espe´rance, “Characterization of manganese-containing particles collected from the exhaust emissions of automobiles running with MMT additive,” Environmental Science and Technology, vol. 33, no. 19, pp. 3341–3346, 1999. [29] C. Colmenares, S. Deutsch, C. Evans et al., “Analysis of manganese particulates from automotive decomposition of methylcyclopentadienyl manganese tricarbonyl,” Applied Sur- face Science, vol. 151, no. 3, pp. 189–202, 1999. [30] N. Mo¨lders, P. J. Schilling, J. Wong, J. W. Rods, and I. L. Smith, “X-ray ﬂuorescence mapping and micro-XANES spectro- scopic characterization of exhaust particulates emitted from 9 auto engines burning MMT-added gasoline,” Environmental Science and Technology, vol. 35, no. 15, pp. 3122–3129, 2001. [31] T. Ressler, J. Wong, J. Roos, and I. L. Smith, “Quantitative speciation of mn-bearing particulates emitted from autos burning (methylcyclopentadienyl) manganese tricarbonyl- added gasolines using XANES spectroscopy,” Environmental Science and Technology, vol. 34, no. 6, pp. 950–958, 2000. [32] M. Aschner, K. M. Erikson, and D. C. Dorman, “Manganese dosimetry: species diﬀerences and implications for neurotox- icity,” Critical Reviews in Toxicology, vol. 35, no. 1, pp. 1–32, 2005. [33] W. K. Boyes and D. B. Miller, “A review of rodent models of manganese neurotoxicity,” Neurotoxicology, abstract 468, 1998. [34] C. W. Olanow, P. F. Good, H. Shinotoh et al., “Manganese intoxication in the rhesus monkey: a clinical, imaging, patho- logic, and biochemical study,” Neurology, vol. 46, no. 2, pp. 492–498, 1996. [35] D. C. Dorman, M. F. Struve, M. W. Marshall, C. U. Parkinson, R. A. James, and B. A. Wong, “Tissue manganese concentra- tions in young male rhesus monkeys following subchronic manganese sulfate inhalation,” Toxicological Sciences, vol. 92, no. 1, pp. 201–210, 2006. [36] D. C. Dorman, M. F. Struve, B. A. Wong, J. A. Dye, and I. D. Robertson, “Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation,” Toxicological Sciences, vol. 92, no. 1, pp. 219–227, 2006. [37] D. C. Dorman, M. F. Struve, E. A. Gross, B. A. Wong, and P. C. Howroyd, “Sub-chronic inhalation of high concentrations of manganese sulfate induces lower airway pathology in rhesus monkeys,” Respiratory Research, vol. 6, article 121, 2005. [38] M. F. Struve, B. E. McManus, B. A. Wong, and D. C. Dorman, “Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation,” American Journal of Industrial Medicine, vol. 50, no. 10, pp. 772–778, 2007. [39] K. M. Erikson, D. C. Dorman, L. H. Lash, and M. Aschner, “Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity,” Toxicological Sciences, vol. 97, no. 2, pp. 459–466, 2007. [40] D. C. Dorman, M. F. Struve, A. Norris, and A. J. Higgins, “Metabolomic analyses of body ﬂuids after subchronic man- ganese inhalation in Rhesus monkeys,” Toxicological Sciences, vol. 106, no. 1, pp. 46–54, 2008. [41] D. Vitarella, R. A. James, K. L. Miller, M. F. Struve, B. A. Wong, and D. C. Dorman, “Development of an inhalation system for the simultaneous exposure of rat dams and pups during developmental neurotoxicity studies,” Inhalation Toxicology, vol. 10, no. 12, pp. 1095–1117, 1998. [42] D. C. Dorman, A. M. McElveen, M. W. Marshall et al., “Maternal-fetal distribution of manganese in the rat following inhalation exposure to manganese sulfate,” NeuroToxicology, vol. 26, no. 4, pp. 625–632, 2005. [43] J. D. Schroeter, A. Nong, M. Yoon et al., “Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models,” Toxicological Sciences, vol. 120, no. 2, pp. 481–498, 2011. [44] D. C. Dorman, M. F. Struve, R. A. James, M. W. Marshall, C. U. Parkinson, and B. A. Wong, “Inﬂuence of particle solubility on the delivery of inhaled manganese to the rat brain: